윤아름 (한양대학교)님 | 한빛사연구자 > 한빛사

한양대학교

최종업데이트

Helical quaternary amine polypeptide programs membrane stress to drive immunogenic cell death and cytosolic gene delivery for cancer immunotherapy
- Biomaterials, Available online 28 May 2026 | https://doi.org/10.1016/j.biomaterials.2026.124337
- 2026-05
- 바이오·의료융합
- 한빛사논문
Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer
- J. Immunother. Cancer, 9 April 2026 | https://doi.org/10.1136/jitc-2025-014508
- 2026-04
- 바이오·의료융합
- 한빛사논문
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in a mouse model of lung cancer
- Mol. Ther., Available online 25 July 2024 | https://doi.org/10.1016/j.ymthe.2024.07.017
- 2024-07
- 의약학
- 한빛사논문
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
- Nucleic Acids Res., 27 July 2017, 45 (13): 7897-7908 | DOI: https://doi.org/10.1093/nar/gkx490
- 2017-07
- 생명과학
- 한빛사논문

연구자 ID

저자논문